<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="pharmaceutical-sciences" lang="en"><front><journal-meta><journal-id journal-id-type="publisher">IJCRR</journal-id><journal-id journal-id-type="nlm-ta">I Journ Cur Res Re</journal-id><journal-title-group><journal-title>International Journal of Current Research and Review</journal-title><abbrev-journal-title abbrev-type="pubmed">I Journ Cur Res Re</abbrev-journal-title></journal-title-group><issn pub-type="ppub">2231-2196</issn><issn pub-type="opub">0975-5241</issn><publisher><publisher-name>Open Science Publishers LLP</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">218</article-id><article-id pub-id-type="doi"/><article-id pub-id-type="doi-url"> https://doi.org/10.31782/IJMPS.2023.13101</article-id><article-categories><subj-group subj-group-type="heading"><subject>Pharmaceutical Sciences</subject></subj-group></article-categories><title-group><article-title>Nanotechnology: Reviewing the New Concept of Drug Delivery&#13;
&#13;
__ampersandsignnbsp;&#13;
&#13;
__ampersandsignnbsp;&#13;
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ansari</surname><given-names>Mojabir Hussen</given-names></name></contrib><contrib contrib-type="author"><name><surname>Yadav</surname><given-names>Sonam S.</given-names></name></contrib></contrib-group><pub-date pub-type="ppub"><day>31</day><month>01</month><year>2023</year></pub-date><volume>1)</volume><issue/><fpage>1</fpage><lpage>8</lpage><permissions><copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p></license></permissions><abstract><p>Nanotechnology is mostly applied in pharmaceutical research for so many reasons, but the real goals are to improve or enhance drug solubility/bioavailability and/or delivery to specific sites of action. Nanotechnology is also used to develop new and effective therapeutic devices. Nanotechnology involves the systematic study of smaller molecular structures with a size range between 0.1 to 100 nm. It is useful in various areas like the subspecialties of medicine such as cardiology, ophthalmology, endocrinology, cancer, and immunology, as well as biophysics, molecular biology, and bioengineering. Pharmaceutical Nanotechnology depends on the methods and principles of Nanoscience and nano medicine to pharmacies to develop new drug delivery systems which can overcome the drawbacks or limitations of conventional drug delivery systems.&#13;
</p></abstract><kwd-group><kwd> Nanotechnology</kwd><kwd> Nano research</kwd><kwd> Therapeutics</kwd><kwd> Nano particles</kwd></kwd-group></article-meta></front></article>
